Amazon & GoodRx Attack US Healthcare Market with Flat-Fee Prescription Model

Amazon and GoodRx are experiencing growing customer numbers in their prescription subscription services as millions of Americans abandon their traditional health insurance due to rising premiums. Both companies' subscription models offer access to prescription medications at monthly flat rates, independent of conventional insurance structures.

Health Insurance Premiums Rise Dramatically

Premiums for ACA (Affordable Care Act) health insurance rose more than 20 percent in 2026, according to a Commonwealth Fund study from September 29, 2026. The Wakely Consulting Group forecast increases of up to 26 percent based on April 2026 data. Employer-sponsored private insurance is expected to become up to 11 percent more expensive in 2027, according to a WTW study from September 2026.

In response, millions of Americans cancelled their individual ACA insurance plans, Reuters reported on September 29, 2026. William Soliman, Chief Investment Officer at White Manna Capital Partners, noted that policyholders with high deductibles are increasingly comparing insurance prices with direct out-of-pocket payment options.

Amazon RxPass Triples User Numbers

Amazon launched RxPass in 2023 as an add-on service to Amazon Pharmacy. The number of users has nearly tripled since launch, according to John Love, Vice President at Amazon Pharmacy, on September 29, 2026. More than 70 percent of users obtain three or more different medications through the service.

RxPass costs $5 per month and covers a range of common prescription medications. According to analyst assessments, the fixed price is easier for consumers to understand than fluctuating coverage structures and deductibles of traditional insurance – an advantage in times of rising and confusing health care costs.

GoodRx Launches Companion Plan

GoodRx introduced its Companion subscription plan in May 2026. For $14.99 per month, customers receive discounts on prescription medications, free access to over 250 generic drugs, and discounted health services.

The company is positioning itself as an alternative to conventional insurance models, targeting the growing group of consumers who find traditional health insurance too expensive or inflexible.

Disruption of the US Health Market

Amazon and GoodRx are deliberately exploiting structural disruptions in the US health insurance market. Both companies directly target consumers who are reducing or abandoning their insurance coverage. The subscription models offer predictable monthly costs instead of hard-to-calculate premiums, deductibles, and variable copayments.

For private investors in the DACH region, this represents an example of business model innovation in a regulated market: while the European health market is heavily state-organized, new commercial opportunities are emerging in the US from gaps in care provision. Amazon leverages its logistics infrastructure and customer base, while GoodRx builds on its established position in pharmaceutical discount services.

Market Outlook and Implications

Rising demand for prescription subscriptions reflects a fundamental shift in the US health market. If insurance premiums continue to rise while low-cost direct offerings become available, the traditional insurance model may lose appeal for chronically ill patients with predictable medication needs.

Amazon benefits from its existing Prime infrastructure and can integrate medication delivery as an additional service. GoodRx is expanding its business model from plain discount codes to comprehensive health services. Both companies, however, face direct competition with each other and with established pharmacy chains that are also developing subscription models.

Whether flat-rate prescriptions will establish themselves long-term as an independent business model or whether regulatory intervention will slow expansion remains to be seen. Current growth figures, however, show that demand exists and traditional insurers are facing pressure.